期刊
DISEASE MODELS & MECHANISMS
卷 4, 期 5, 页码 596-606出版社
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dmm.007716
关键词
-
资金
- Down Syndrome Research and Treatment Foundation
- National Institute of Child Health & Human Development [R01HD038384]
Remarkable advances have been made in recent years towards therapeutics for cognitive impairment in individuals with Down syndrome (DS) by using mouse models. In this review, we briefly describe the phenotypes of mouse models that represent outcome targets for drug testing, the behavioral tests used to assess impairments in cognition and the known mechanisms of action of several drugs that are being used in preclinical studies or are likely to be tested in clinical trials. Overlaps in the distribution of targets and in the pathways that are affected by these diverse drugs in the trisomic brain suggest new avenues for DS research and drug development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据